Family Medicine Residency, Mayo Clinic Graduate Medical Education
Doctor of Osteopathic Medicine (DO), Burrell College of Osteopathic Medicine
BA, Environmental Science – Public Health Emphasis, Willamette University
Dr. Janitz completed his osteopathic medical degree in 2023 and is a current family medicine resident at Mayo Clinic in Florida. His past research experiences and publications include bilateral linear porokeratosis treated with a novel cholesterol/lovastatin cream, post-infantile giant cell autoimmune hepatitis associated with rheumatoid arthritis, and malaria/Lyme disease habitat suitability in the pacific northwest using GIS modeling. Dr. Janitz gets a thrill from presenting his research at conferences and has won multiple awards for his manuscripts, including “Best Case Study” at the National Student of Osteopathic Medical Association research symposium. He loves partnering with students to foster their passions and guide their work within the Rising Researchers program.
Tyler’s Research Focus
- Neurologic Conditions: CTE, Concussions, Epilepsy
- Musculoskeletal Conditions: Joint Pathologies, Ligamentous Injuries
- Chronic Disease Management
- Autoimmune Disease Management
- Socioeconomic and Environmental Impact on Public Health
Tyler’s Scholarly Activity:
Martinez-Moad M, Wunderlich G, Diep D, Vasudevan A, Russell A, Janitz T, Aluri B. Oviedo A, Mysore A. Post-Infantile Giant Cell Hepatitis Associated with Rheumatoid Arthritis. American College of Gastroenterology (ACG) Case Report Journal. 2023: 10(4): p e01006. doi:10.14309/crj.0000000000001006
Diep D, Janitz T, Kannan K S, Crane A, Aluri B, Wright K, Baker B. Bilateral Linear Porokeratosis Treated With Topical Cholesterol 2%/Lovastatin 2%. Cureus. 2022,14(7): e27540. doi:10.7759/cureus.27540
Martinez-Moad M, Diep D, Wunderlich G, Vasudevan A, Janitz T, Crane A, Aluri B. Post-Infantile Giant Cell Hepatitis Associated with Rheumatoid Arthritis. 2022 AAFP Family Medicine Experience (FMX). September 2022. Poster Presentation.
Diep D, Janitz T, Crane A, Kannan K, Aluri B, Sudarsan R, Wright K, Baker W. Comparison of Topical Cholesterol 2%/ Lovastatin 2% vs Lovastatin 2% in Treating Bilateral Linear Porokeratosis. 2nd Annual Skin Cancer Symposium + Symposium for Inflammatory Skin Diseases. June 2022. Poster Presentation.
Diep D, Janitz T, Crane A, Aluri B, Baker W. Bilateral Linear Porokeratosis Treated With Compounded Topical Cholesterol 2%/Lovastatin 2% Cream. 2022 National SOMA Research Symposium. April 2022. Oral Presentation.
Diep D, Janitz T, Crane A, Aluri B, Baker W. Bilateral Linear Porokeratosis Treated With Compounded Topical Cholesterol 2%/Lovastatin 2% Cream. Medical Center of the Americas 2022 Virtual Bioscience Poster Session. February 2022. Poster Presentation.
Janitz T, Diep D, Crane A, Aluri B, Baker W. Bilateral Linear Porokeratosis Treated With Compounded Topical Cholesterol 2%/Lovastatin 2% Cream. New Mexico Academy of Family Physicians (NMAFP) 2022 Winter Refresher Conference. February 2022. Poster Presentation.
Janitz T, Craig D. Vector Disease Habitat Suitability in Oregon: a projection of Lyme Disease and Malaria in Oregon based on interviews with public health officials, GIS modeling of climate projection/habitat suitability, and biological research. Willamette University Student Scholarship Recognition Day. April 2019. Poster Presentation.